Why scientific details are important when novel technologies encounter law, politics, and ethics

Journal of Law, Medicine and Ethics

Volumn 38, Issue 2, 2010, Pages 204-211

  Goldstein, Lawrence ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BIOMEDICINE; CONFERENCE PAPER; CONFLICT; EMBRYO RESEARCH; EMBRYONIC STEM CELL; ETHICS; FERTILIZATION IN VITRO; GENETICS; HUMAN; HUMAN EXPERIMENT; LEGAL ASPECT; POLITICS; SAFETY; UNITED STATES;

ALZHEIMER DISEASE; BIOLOGICAL SCIENCE DISCIPLINES; DISSENT AND DISPUTES; EMBRYO RESEARCH; EMBRYONIC STEM CELLS; FERTILIZATION IN VITRO; HUMAN EXPERIMENTATION; HUMANS; POLITICS; SAFETY; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES;

EID: 77954926626     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/j.1748-720X.2010.00480.x     Document Type: Conference Paper

References (14)

1. National Research Council Committee on the Biological and Biomedical Applications of Stem Cell Research. Stem Cells and the Future of Regenerative Medicine 2002, Washington, D.C., National Academy Press, at xv, 94 [hereinafter cited as NRCC]
2. Weiss R. " Stem Cells an Unlikely Therapy for Alzheimer's,": Washington Post. June 10, 2004, A03. http://www.washingtonpost.com/wp-dyn/articles/A29561-2004Jun9.html, at, , last visited March 18, 2010
3. Weiss R. " Stem Cell Fairy Tales and Stem Cell Fables," http://www.scienceprogress.org/2009/03/stem-cell-fairy-tales/, last visited March 18, 2010
4. " 2009 Alzheimer's Disease Facts and Figures," Alzheimers & Dementia 2009, 5(no. 3):234-270. I. Mebane-Sims, and Alzheimer's Association
5. http://www.clinicaltrials.gov, See, for more information
6. Selkoe D J. " Alzheimer's Disease Is a Synaptic Failure," Science 2002, 298(no. 5595):789-791.
7. Hardy J, Selkoe D J. " The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics," Science 2002, 297(no. 5580):353-356.
8. See NRCC, note 1.
9. Testimony of Senator Sam Brownback (R-KS) to Senate Appropriations Committee-Subcommittee on Labor, Health and Human Services, Education and Related Agencies, April 26, 2000.
10. Voltarelli J C, Couri C E. " Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus," JAMA 2007, 297(no. 14):1568-1576.
11. Couri C E, Oliveira M C. " C-Peptide Levels and Insulin Independence Following Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus," JAMA 2009, 301(no. 15):1573-1579.
12. Skyler J S. " Cellular Therapy for Type 1 Diabetes: Has the Time Come?" JAMA 2007, 297(no. 14):1599-1600.
13. Rose D. " Diabetics Cured in Stem-Cell Treatment Advance,": The Times (London). April 11, 2007, http://www.timesonline.co.uk/tol/life_and_style/health/article1637528.ece, last visited March 18, 2010
14. Amariglio N, Hirshberg A. " Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient," PLoS Medicine 2009, 6(no. 2):e1000029.